Skip to main content

Table 2 Estimated number of cases successfully treated and average cost-effectiveness

From: A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia

Effects/cost

AL

SP

1. Patients starting treatment (2005)

55509

55509

2. Efficacy

98.2%

68.4%

3. Patient Compliance

75.1%

85.0%

4. Treatment successful despite less than full compliance

50%

0

5. Number of cases successfully treated*

47560

32273

6. Total expenditure on treating malaria

406370.69

343743.64

7. Average Cost-effectiveness Ratio (average cost per case cured)

$8.57

$10.65

8. Incremental cost per case successfully treated

4.10

-

  1. Items in Rows 5, 6, 7 and 8 estimated from formula in section 3. Input data on efficacy and compliance obtained from surveys [12-16].